dual gip/glp-1 receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1/GIP Dual Receptor Agonist -
Description
GLP-1RAs such as semaglutide have proven efficacy in HFpEF and are being studied in people with PD as well as in trials for Alzheimers disease
doi: 10.2337/db14-0100
Diabetes Care 44(3):765773 Kim WJ, Lee SJ, Lee E, Lee EY, Han K (2022) Risk of incident dementia according to glycemic status and comorbidities of hyperglycemia: a nationwide population-based cohort study
Tian F, Xu W, Chen L, Chen T, Feng X, Chen J, et al
Generative AI statement The author(s) declare that no Generative AI was used in the creation of this manuscript
